Cargando…

Management of Drug–Drug Interactions among Critically Ill Patients with Chronic Kidney Disease: Impact of Clinical Pharmacist's Interventions

BACKGROUND AND OBJECTIVES: Drug–drug interactions (DDIs) can create a burden on prescribers to preserve patient safety. This study aimed to identify common DDIs in critically ill patients with chronic kidney disease (CKD) and to evaluate clinical pharmacist's interventions in managing DDIs amon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aghili, Mina, Kasturirangan, Meera Neelathahalli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608633/ https://www.ncbi.nlm.nih.gov/pubmed/34866818 http://dx.doi.org/10.5005/jp-journals-10071-23919

Ejemplares similares

Drug Interaction and Pharmacist
por: Ansari, JA
Publicado: (2010)

Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions
por: Langness, Jacob A, et al.
Publicado: (2017)

Retrospective drug utilization review: impact of pharmacist interventions on physician prescribing
por: Angalakuditi, Mallik, et al.
Publicado: (2011)

Impact of pharmacist’s interventions on cost of drug therapy in intensive care unit
por: Saokaew, Surasak, et al.
Publicado: (2009)

The Practice of the Community Pharmacists in Managing Potential Drug-Drug Interactions: A Simulated Patient Visits
por: Hamadouk, Riham M, et al.
Publicado: (2022)

Impact of a multidisciplinary approach involving clinical pharmacist on resolving drug related problems in chronic kidney patients: a prospective interventional study
por: Pehlivanli, Aysel, et al.
Publicado: (2023)

Impact of Clinical Pharmacist's Interventions on Potential Drug–Drug Interactions in the Cardiac Care Units of Two University Hospitals in Shiraz, South of Iran
por: Shafiekhani, Mojtaba, et al.
Publicado: (2019)

Nephrotoxic drug burden among 1001 critically ill patients: impact on acute kidney injury
por: Ehrmann, Stephan, et al.
Publicado: (2019)

Preferences of Patients and Pharmacists with Regard to the Management of Drug–Drug Interactions: A Choice-Based Conjoint Analysis
por: Heringa, Mette, et al.
Publicado: (2017)

Drug Interactions of Chronic Neuropsychiatric Drugs in Neuro-critical Care
por: A, Shobhana
Publicado: (2019)

Drug-induced kidney injury in Chinese critically ill pediatric patients
por: Hu, Biwen, et al.
Publicado: (2022)

Drug related problems in admitted geriatric patients: the impact of clinical pharmacist interventions
por: Hailu, Berhane Yohannes, et al.
Publicado: (2020)

Drug-drug interactions and pharmacists’ interventions among psychiatric patients in outpatient clinics of a teaching hospital in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2019)

Important drug classes associated with potential drug–drug interactions in critically ill patients: highlights for cardiothoracic intensivists
por: Baniasadi, Shadi, et al.
Publicado: (2015)

Food-drug interactions: Knowledge among pharmacists in Jordan
por: Zawiah, Mohammed, et al.
Publicado: (2020)

Impact of the use of nephrotoxic drugs in critically ill pediatric patients
por: Almeida, Jáder Pereira, et al.
Publicado: (2020)

Impact of a Pharmacist-Led Chronic Disease State Management Clinic on Patient Assessment of Chronic Illness Care
por: Buatois, Emily M, et al.
Publicado: (2022)

Pharmacist's drug handbook.
Publicado: (2001)

Impactful Policy Action to Reduce Drug Costs in Managing Critically Ill Patients with COVID-19
por: Tichy, Eric M., et al.
Publicado: (2020)

Skin disorder management in oral anticancer drugs by collaboration of hospital pharmacists and community pharmacists
por: Urakawa, Ryuta, et al.
Publicado: (2020)

Prospective Observational Evaluation of Incidences and Implications of Drug-Drug Interactions Induced Adverse Drug Reactions in Critically Ill Patients
por: Ray, S., et al.
Publicado: (2010)

Antiepileptic drugs in critically ill patients
por: Farrokh, Salia, et al.
Publicado: (2018)

Pharmacist Intervention in Safe and Effective Conversion of Brand to Generic Drugs
por: Summers, Kent H.
Publicado: (2005)

The Role of Community Pharmacists in the Detection of Clinically Relevant Drug-Related Problems in Chronic Kidney Disease Patients
por: Mongaret, Céline, et al.
Publicado: (2020)

Evaluation of community pharmacists’ knowledge about drug–drug interaction in Central Saudi Arabia
por: Alrabiah, Ziyad, et al.
Publicado: (2019)

Assessment of community pharmacists’ knowledge about drug-drug interactions in Jeddah, Saudi Arabia
por: Alorfi, Nasser M., et al.
Publicado: (2023)

Pharmacist knowledge of gout management: impact of an educational intervention
por: Dorris, Emma R., et al.
Publicado: (2022)

Drug Dosing in Critically Ill Patients with Acute Kidney Injury and on Renal Replacement Therapy
por: Saran, Sai, et al.
Publicado: (2020)

Preventable adverse drug events in critically ill HIV patients: Is the detection of potential drug-drug interactions a useful tool?
por: Ramos, Grazielle Viana, et al.
Publicado: (2018)

Vancomycin Prescribing Practices and Therapeutic Drug Monitoring for Critically Ill Neonatal and Pediatric Patients: A Survey of Physicians and Pharmacists in Hong Kong
por: Chow, Twinny Cheuk Hin, et al.
Publicado: (2020)

Role of pharmacists in retailing of drugs
por: Sinha, Hemant Kumar
Publicado: (2014)

Clinical pharmacists’ interventions and therapeutic drug monitoring in patients with mycobacterial infections
por: Woods, Anna M., et al.
Publicado: (2023)

Oral Drug Absorption and Drug Disposition in Critically Ill Cardiac Patients
por: Harnisch, Lars-Olav, et al.
Publicado: (2023)

Rifampicin and anti-hypertensive drugs in chronic kidney disease: Pharmacokinetic interactions and their clinical impact
por: Agrawal, A., et al.
Publicado: (2016)

Minimising drug errors in critically ill patients
por: Carson-Stevens, Andrew, et al.
Publicado: (2011)

Insulin: a wonder drug in the critically ill?
por: Johan Groeneveld, AB, et al.
Publicado: (2002)

Multiorgan Drug Action of Levosimendan in Critical Illnesses
por: Pan, Jian, et al.
Publicado: (2019)

The Impact of Pharmacist-Led Medication Management Services on the Quality of Life and Adverse Drug Reaction Occurrence
por: Brajković, Andrea, et al.
Publicado: (2022)

Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection
por: Molino, Caroline de Godoi Rezende Costa, et al.
Publicado: (2014)

Impact of the COVID-19 pandemic on drug-related problems and pharmacist interventions in geriatric acute care units
por: Chappe, M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_71o01bf24epqk7q4j7kecbk2kb